Does scopolamine improve attention more than placebo in healthy volunteers and what does this tell us about mechanisms of attention?

Phase 4

• Conditions: Normal attention and cognitive functioning; Neurological - Studies of the normal brain and nervous system; Mental Health - Studies of normal psychology, cognitive function and behaviour; ormal attention and cognitive functioning

• Registration Number: ACTRN12611000603910
• Lead Sponsor: The University of Queensland

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2011-06-10
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: Male
• Target Recruitment: 25

Inclusion Criteria

Healthy volunteers
Aged 18-40 years
Male

Exclusion Criteria

Current psychiatric or neurological diagnosis
Current use of psychotropic medication
Current use of cholinergic or anticholinergic medication
Medical condition in which scopolamine is contraindicated

Study & Design

• Study Type: Interventional
• Study Design: Not specified